Cargando…
Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma
BACKGROUND: The Vk*MYC transgenic and transplant mouse models of multiple myeloma (MM) are well established as a research tool for anti-myeloma drug discovery. However, little is known of the immune response in these models. Understanding the immunological relevance of these models is of increasing...
Autores principales: | Cooke, Rachel E., Gherardin, Nicholas A., Harrison, Simon J., Quach, Hang, Godfrey, Dale I., Prince, Miles, Koldej, Rachel, Ritchie, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011922/ https://www.ncbi.nlm.nih.gov/pubmed/27599546 http://dx.doi.org/10.1186/s12967-016-0994-6 |
Ejemplares similares
-
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells
por: Cooke, Rachel Elizabeth, et al.
Publicado: (2020) -
Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?
por: Cooke, Rachel E., et al.
Publicado: (2019) -
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
por: Bradey, Alanah L., et al.
Publicado: (2022) -
Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar
por: Kim, Tong-Soo, et al.
Publicado: (2010) -
VK210 and VK247 genotypes of Plasmodium vivax in anopheline mosquitoes from Brazilian Amazon
por: Santos, Erian de Almeida, et al.
Publicado: (2019)